Serum circulating free DNA of syncytin-1 as a novel molecular marker for early diagnosis of non-small-cell lung cancer.
Sign Up to like & getrecommendations! Published in 2023 at "Biomarkers in medicine"
DOI: 10.2217/bmm-2022-0499
Abstract: Background: Liquid biopsy has been receiving attention as an emerging detection technology in the clinical application of non-small-cell lung cancer (NSCLC). Methods: We quantified serum circulating free DNA (cfDNA) of syncytin-1 in 126 patients and… read more here.
Keywords: lung cancer; cfdna syncytin; non small; syncytin ... See more keywords